April 18, 2018 / 1:20 PM / a month ago

BRIEF-Insys Therapeutics To Advance Clinical Research Of Dronabinol Inhalation Using Novel Breath-Actuated Device

April 18 (Reuters) - INSYS Therapeutics Inc:

* INSYS THERAPEUTICS TO ADVANCE CLINICAL RESEARCH OF DRONABINOL INHALATION USING NOVEL BREATH-ACTUATED DEVICE

* INSYS THERAPEUTICS - PLANS TO ADVANCE CLINICAL RESEARCH OF DRONABINOL INHALATION, ACCEPTED BY U.S. FDA UNDER IND FILING IN H2 2018. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below